Skip to main content

Table 2 Site-specific percentage of unstage cancer, malignant cancer incidence rates, and 5-year relative survival according to race and sex

From: Unstaged cancer in the United States: a population-based study

 

White Males

White Females

Black Males

Black Females

 

Unstage

%*

Malignant

Incidence

Rate†

5-yr Survival

%‡

Unstage

%*

Malignant

Incidence

Rate†

5-yr Survival

%‡

Unstage

%*

Malignant

Incidence

Rate†

5-yr Survival

%‡

Unstage

%*

Malignant

Incidence

Rate†

5-yr Survival

%‡

Liver

20.3

7.9

10.9

24.0

2.5

12.9

17.8

12.8

6.4

18.9

3.6

9.9

Pancreas

14.4

13.1

4.4

15.7

10.2

4.6

13.9

16.5

3.9

16.1

14.3

5.2

Esophagus

13.9

8

14.1

21.1

1.9

14.2

16.7

9.6

7.2

22.6

3.0

10.3

Stomach

12.1

9.9

18.6

14.9

4.7

23.5

14.5

17.2

19.5

15.6

9.0

25.4

Lung and bronchus

8.6

78.9

12.9

8.4

54.9

17.7

8.2

106.1

10.7

7.4

54.3

14.4

Soft tissues

7.7

3.9

66.5

7.4

2.7

66.5

8.6

3.6

60.2

6.7

3.1

63.4

Rectum

7.1

12.7

60.4

7.9

7.6

61.6

11.3

12.4

51.9

11.8

8.5

57.5

Oral cavity and pharynx

6.3

15.8

58.2

6.6

6.1

61.3

6.5

16.9

33.1

6.9

5.7

49.9

Colon

5.2

40.5

61.6

5.3

32

61.3

7.0

52.7

53.3

6.8

42.3

53.8

Kidney and renal pelvis

5.2

19.1

63.9

5.2

9.7

64.1

7.0

21.3

60.8

6.7

10.4

64.2

Prostate

4.9

158

93.4

   

5.4

248.2

88.9

   

Melanoma of the skin

3.8

28.9

86.8

3.8

18.6

92.2

8.3

1.1

65.1

11.1

0.9

76.1

Urinary bladder

3.2

40.6

80.9

4.0

9.9

75.8

5.4

20.5

67.7

5.2

7.6

53.4

Thyroid

2.0

5.1

93.5

2.1

14.7

97.4

3.7

2.7

88.8

2.4

8.2

94.9

Female Breast

   

2.1

130.7

86.1

   

3.0

119.1

73.5

Corpus Uteri

   

3.3

24

86

   

5.7

19.2

60.8

Cervix

   

4.8

8.3

71.3

   

7.4

10.7

61.1

Ovary

   

7.1

14.1

42.9

   

10.8

10.1

38.8

Spearman's Rho

 

-0.38

-0.92

 

-0.62

-0.93

 

-0.31

-0.80

 

-0.32

-0.70

P Value

 

0.179

< 0.001

 

0.008

< 0.001

 

0.283

< 0.001

 

0.216

0.002

  1. Data source: Surveillance, Epidemiology and End Results (SEER) Program, 2000-2007.
  2. *Age-adjusted to the 2000 US standard population.
  3. †Age-adjusted to the 2000 US standard population and expressed per 100,000.
  4. ‡Relative survival, which is a net survival measure representing cancer survival in the absence of other causes of death.